HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Fluidigm Corporation (FLDM)
7.52  0.09  (1.21%) 08-13 00:40
Open: 7.53 High: 7.59
Pre.close: 7.43 Low: 7.15
Volume: 1,994,515 Ave vol: 3,098,814
52w High: 9.26 52w Low: 1.17
MA(50): 5.654 MA(200): 3.899
EPS: -0.778 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.fluidigm.com
Market Cap (M): 536
Shares Out (M): 71
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 10.82 Target 2: 12.63
Resist 1: 9.26 Resist 2: 10.82
Support 1: 6.66 Support 2: 5.06
Company key metrics
Revenue per Share: 1.7557
Net Income per Share: -0.9702
Cash per Share: 0.3244
Book Value per Share: 2.3003
Price to Sales: 2.2384
Price to Book Value: 1.7085
Earnings Yield: -0.2469
Dividend Yield: 0
Debt to Equity: 0.7239
Debt to Assets: 0.4199
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Mon, 10 Aug 2020
Fluidigm Corporation (FLDM) Fundamental and Technical Analysis Explained - The News Heater

Mon, 10 Aug 2020
What Is The Ownership Structure Like For Fluidigm Corporation (NASDAQ:FLDM)? - Simply Wall St

Mon, 10 Aug 2020
How Much Of Fluidigm Corporation (NASDAQ:FLDM) Do Institutions Own? - Simply Wall St

Fri, 07 Aug 2020
Implied Volatility Surging for Fluidigm (FLDM) Stock Options - Yahoo Finance

Thu, 06 Aug 2020
Fluidigm Announces Second Quarter 2020 Financial Results - Yahoo Finance

Mon, 03 Aug 2020
Fluidigm COVID-19 Funding, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.